Search results
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 1 day agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi By Investing.com
Investing.com· 18 hours agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 3 days agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WKBN 27 Youngstown· 3 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 3 days agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
Novavax erases doubts about its ability to remain in business
WSAU Wausau· 3 days ago(Reuters) - COVID-19 vaccine maker Novavax, on Friday, erased doubts about its ability to remain in...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 2 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Trending tickers: TSMC, Novavax, Anglo American and IAG
Yahoo Finance UK· 3 days agoNovavax will receive $500m in upfront payments as well as $700m in development, regulatory and...
An adjuvant made in yeast could lower vaccine cost and boost availability
UC Berkeley NewsCenter· 5 days agoVaccines save lives, as proven during the recent pandemic, but one component of most vaccines —...